🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

67 results for “Amgen Technology (Ireland) UC” Clear

  1. Placebo for Maridebart cafraglutide, AMG 133, AMG 133, AMG 133, AMG 133

    Amgen Technology (Ireland) UC

    Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

    phase 3 small molecule active

    1 trial

  2. Rocatinlimab, Placebo for AMG 451

    Amgen Technology (Ireland) UC

    Prurigo Nodularis

    phase 3 small molecule active

    1 trial

  3. SOTORASIB, Dexamethasone 2mg Tablets, DOCETAXEL

    Amgen Technology (Ireland) UC

    Previously treated locally advanced and unresectable or metastatic non-small cell lung cancer (NSCLC) with KRAS p.G12C mutation

    phase 3 small molecule active

    1 trial

  4. SOTORASIB, Stivarga 40 mg film-coated tablets, Lonsurf 20 mg/8.19 mg film-coated tablets, Vectibix 20 mg/ml concentrate for solution for infusion, Stivarga 40 mg film-coated tablets, Vectibix 20 mg/ml concentrate for solution for infusion, Lonsurf 15 mg/6.14 mg film-coated tablets

    Amgen Technology (Ireland) UC

    Colorectal Cancer (CRC)

    phase 3 small molecule active

    1 trial

  5. SYLVANT 400 mg powder for concentrate for solution for infusion, ABIRATERONE ACETATE, AMG 509, ABIRATERONE ACETATE, ENZALUTAMIDE, AMG 509, AMG 509, CABAZITAXEL

    Amgen Technology (Ireland) UC

    Metastatic castration-resistant prostate cancer (mCRPC)

    phase 3 small molecule active

    1 trial

  6. TOCILIZUMAB, Tarlatamab, DEXAMETHASONE, Placebo for Tarlatamab (AMG-757), PARACETAMOL , ELECTROLYTES , PREDNISOLONE , Tarlatamab, VASOPRESSIN (ARGIPRESSIN) , SILTUXIMAB

    Amgen Technology (Ireland) UC

    Limited-Stage Small-Cell Lung Cancer (LS SCLC)

    phase 3 small molecule active

    1 trial

  7. A Phase 2 Long-Term Extension (LTE) Study to Evaluate The Safety and Efficacy of Efavaleukin Alfa in Subjects With Moderately to Severely Active Ulcerative Colitis

    Amgen Technology (Ireland) UC

    Ulcerative Colitis (UC)

    phase 2 other active

    1 trial

  8. A Phase 2, Dose-finding, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of Efavaleukin Alfa Induction Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis

    Amgen Technology (Ireland) UC

    Ulcerative Colitis (UC)

    phase 2 other active

    1 trial

  9. AMG 133, Placebo for AMG 133

    Amgen Technology (Ireland) UC

    Overweight and Obesity

    phase 2 small molecule active

    1 trial

  10. AMG 193

    Amgen Technology (Ireland) UC

    Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  11. AMG 193, AMG 193, AMG 193

    Amgen Technology (Ireland) UC

    Advanced MTAP-null solid tumors

    phase 2 small molecule active

    1 trial

  12. AMG 193, IDE397, AMG 193, IDE397, AMG 193

    Amgen Technology (Ireland) UC

    In Part 1, subjects with advanced MTAP-null solid tumors and, in Part 2, subjects with advanced MTAP-null Non Small-Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  13. AMG 732

    Amgen Technology (Ireland) UC

    Thyroid Eye Disease

    phase 2 small molecule active

    1 trial

  14. Bemarituzumab

    Amgen Technology (Ireland) UC

    Solid tumours

    phase 2 small molecule active

    1 trial

  15. Blinatumomab SC2

    Amgen Technology (Ireland) UC

    Relapsed/Refractory (R/R) and Minimal Residual Disease Positive (MRD+) B-Cell Precursor Acute Lymphoblastic Leukemia

    phase 2 small molecule active

    1 trial

  16. DEXAMETHASONE, CYCLOPHOSPHAMIDE, VINCRISTINE SULFATE, METHOTREXATE, LEVETIRACETAM, Blinatumomab SC2, Blinatumomab SC1, CYTARABINE

    Amgen Technology (Ireland) UC

    Relapsed or Refractory B cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL) and Minimal Residual Disease Positive (MRD+) B-ALL,

    phase 2 small molecule active

    1 trial

  17. Placebo for AMG 133, AMG 133

    Amgen Technology (Ireland) UC

    Type 2 Diabetes Mellitus

    phase 2 small molecule active

    1 trial

  18. Placebo for AMG 451, Rocatinlimab

    Amgen Technology (Ireland) UC

    Moderate-to-severe Asthma

    phase 2 small molecule active

    1 trial

  19. Placebo for AMG 732 will consist of site-sourced normal saline in sterile single-use vials or ampoules, AMG 732

    Amgen Technology (Ireland) UC

    Thyroid Eye Disease

    phase 2 small molecule active

    1 trial

  20. SILTUXIMAB, Tarlatamab, Tarlatamab

    Amgen Technology (Ireland) UC

    Small Cell Lung Cancer (SCLC)

    phase 2 small molecule active

    1 trial

  21. SOTORASIB

    Amgen Technology (Ireland) UC

    KRAS p.G12C Mutant Advanced Solid Tumors

    phase 2 small molecule active

    1 trial

  22. SOTORASIB

    Amgen Technology (Ireland) UC

    Non-small cell lung cancer (NSCLC)

    phase 2 small molecule active

    1 trial

  23. Tarlatamab, TARLATAMAB, Tarlatamab, SILTUXIMAB

    Amgen Technology (Ireland) UC

    Relapsed/Refractory Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  24. Uplizna 100 mg concentrate for solution for infusion

    Amgen Technology (Ireland) UC

    Immunoglobulin G4 related Disease (IgG4-RD)

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources